发明名称 NITROGEN-CONTAINING CYCLIC COMPOUND AND PHARMACEUTICAL COMPOSITION CONTAINING THE COMPOUND
摘要 Novel compounds exhibiting excellent calcium antagonism, particularly neuroselective calcium antagonism, namely, compounds of the general formula (I), salts of the same, or hydrates of both wherein Ar is a group derived fr om an optionally substituted 5- to 14-membered aromatic ring, or the like; the ring A is one member selected from among piperazine, homopiperazine, piperidine and so on; the ring B is an optionally substituted C3-14 hydrocarbon ring or the like; E is a single bond, -CO-, or the like; X is a single bond, oxygen, or the like; R1 is hydrogen, halogeno, hydroxyl, or the like; and D1, D2, W1 and W2 are each independently a single bond or optional ly substituted C1-6 alkylene.
申请公布号 CA2398409(A1) 申请公布日期 2001.07.26
申请号 CA20012398409 申请日期 2001.01.18
申请人 EISAI CO., LTD. 发明人 KANEKO, TOSHIHIKO;YAMAMOTO, NOBORU;KANEDA, YOSHIHISA;KIMURA, MANAMI;SUZUKI, YUICHI;TERAMOTO, TETSUYUKI;IIMURA, YOICHI;YOSHIKAWA, YUKIE;SHINMYO, DAISUKE;KURUSU, NOBUYUKI;NIIDOME, TETSUHIRO;HATAKEYAMA, SHINJI
分类号 A61K31/395;A61P9/10;C07D207/09;C07D207/14;C07D207/16;C07D207/32;C07D207/337;C07D209/14;C07D209/42;C07D211/22;C07D211/26;C07D211/32;C07D211/34;C07D211/46;C07D211/58;C07D211/64;C07D213/36;C07D213/38;C07D213/57;C07D213/74;C07D215/06;C07D215/12;C07D215/22;C07D215/227;C07D215/38;C07D217/04;C07D217/22;C07D235/10;C07D235/14;C07D235/30;C07D241/04;C07D243/08;C07D261/08;C07D263/20;C07D263/32;C07D263/58;C07D271/06;C07D277/28;C07D277/42;C07D277/82;C07D295/14;C07D295/145;C07D295/185;C07D295/192;C07D295/215;C07D307/52;C07D307/54;C07D307/81;C07D319/20;C07D333/24;C07D333/28;C07D333/38;C07D333/60;C07D401/04;C07D401/06;C07D401/12;C07D403/04;C07D405/06;C07D409/00;C07D409/06;C07D409/12;C07D409/14;C07D413/04;C07D413/12;C07D413/14;C07D417/04;C07D417/08;C07D417/12;C07D471/10;C07D487/08;(IPC1-7):C07D409/06 主分类号 A61K31/395
代理机构 代理人
主权项
地址